Atea Pharmaceuticals (AVIR) Prepaid Assets (2020 - 2022)

Atea Pharmaceuticals has reported Prepaid Assets over the past 3 years, most recently at $12.4 million for Q3 2022.

  • Quarterly results put Prepaid Assets at $12.4 million for Q3 2022, up 278.76% from a year ago — trailing twelve months through Sep 2022 was $12.4 million (up 278.76% YoY), and the annual figure for FY2021 was $8.0 million, up 6.4%.
  • Prepaid Assets for Q3 2022 was $12.4 million at Atea Pharmaceuticals, up from $5.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for AVIR hit a ceiling of $12.4 million in Q3 2022 and a floor of $3.0 million in Q3 2020.
  • Median Prepaid Assets over the past 3 years was $6.4 million (2021), compared with a mean of $6.4 million.
  • Biggest five-year swings in Prepaid Assets: increased 6.4% in 2021 and later surged 278.76% in 2022.
  • Atea Pharmaceuticals' Prepaid Assets stood at $7.5 million in 2020, then grew by 6.4% to $8.0 million in 2021, then surged by 55.03% to $12.4 million in 2022.
  • The last three reported values for Prepaid Assets were $12.4 million (Q3 2022), $5.0 million (Q2 2022), and $7.7 million (Q1 2022) per Business Quant data.